Transverse Myelitis — Research Summary
Printed from RareWays (rareways.com.au) on 10 June 2026
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
When Lupus Hits the Spine: A Case of Extensive Transverse Myelitis.
Diogo J et al. — Irish medical journal (19 March 2026)
https://pubmed.ncbi.nlm.nih.gov/41869999/
- 2.
Effective Short-Interval Intravenous Immunoglobulin Reinfusion in Steroid-Unresponsive Pediatric Myelin Oligodendrocyte Glycoprotein-Associated Disease.
Alagarsamy Divya et al. — Journal of child neurology (10 March 2026)
https://pubmed.ncbi.nlm.nih.gov/41804774/
- 3.
Relapse risk factors in double seronegative neuromyelitis optica spectrum disorder: Insights from a multicenter study.
Vallejos Gerome et al. — Multiple sclerosis and related disorders (7 March 2026)
https://pubmed.ncbi.nlm.nih.gov/41806508/
- 4.
Clinical, radiological, and CSF features distinguishing spinal dural arteriovenous fistula from idiopathic transverse myelitis and seropositive NMOSD-/MOGAD-associated myelopathy: a retrospective observational study.
Sarıdaş Furkan et al. — Scientific reports (6 March 2026)
https://pubmed.ncbi.nlm.nih.gov/41792244/
- 5.
Cervical Myelitis Masquerading as Guillain-Barré Syndrome: A Case of Acute Flaccid Tetraplegia With a Sensory Level at the Third Cervical Dermatome.
Ouatab Yasser et al. — Cureus (1 March 2026)
https://pubmed.ncbi.nlm.nih.gov/41930074/
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Transverse Myelitis
Transverse Myelitis is an inflammatory condition affecting the spinal cord that disrupts the nerve signals running through it, causing weakness, sensory disturbances, and bladder or bowel dysfunction. It can be idiopathic or a manifestation of NMOSD, MS, or other autoimmune diseases. Recovery varies widely from complete to significant permanent disability.
Most Recent Research
PRESENTATION: The patient presented with acute urinary retention, fever (39°C), and rapidly progressive bilateral lower limb weakness progressing to flaccid paraplegia (0/5 MRC) with a T6 sensory level. DIAGNOSIS: MRI spine demonstrated longitudinally extensive T2-hyperintense intramedullary lesions from T6 to the conus. CSF analysis showed lymphocytic pleocytosis and elevated protein; autoimmune serology confirmed active systemic lupus erythematosus (SLE). SLE-associated longitudinally extensive transverse myelitis (LETM) was diagnosed following exclusion of other differential diagnoses. TREATMENT: High-dose intravenous methylprednisolone, intravenous immunoglobulin (IVIg), and rituximab were administered. Corticosteroids precipitated psychosis, managed with antipsychotics. Maintenance therapy with mycophenolate mofetil and hydroxychloroquine was continued. Despite aggressive immunotherapy, there was no neurological recovery, and the patient remained paraplegic with neurogenic bowel and bladder dysfunction. DISCUSSION: This case underscores LETM as a rare, aggressive manifestation of SLE that can occur even in patients of European ancestry. Despite prompt multimodal immunotherapy, neurological recovery was absent, reflecting the poor prognosis of extensive cord involvement. Early recognition, exclusion of mimics, and coordinated multidisciplinary care are vital to optimise outcomes and quality of life.
Common Questions
What is Transverse Myelitis?
Transverse Myelitis is an inflammatory condition affecting the spinal cord that disrupts the nerve signals running through it, causing weakness, sensory disturbances, and bladder or bowel dysfunction. It can be idiopathic or a manifestation of NMOSD, MS, or other autoimmune diseases. Recovery varies widely from complete to significant permanent disability.
How many clinical trials are available for Transverse Myelitis?
RareWays currently indexes 17 clinical trials for Transverse Myelitis, of which 3 are actively recruiting. Trial availability changes as new studies are registered — check the trials tab for current status.
Where does the research data for Transverse Myelitis come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Transverse Myelitis.
No spam. Unsubscribe any time. Not medical advice.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.